Growth Metrics

Biohaven (BHVN) Net Cash Flow (2021 - 2026)

Biohaven has reported Net Cash Flow over the past 6 years, most recently at $44.3 million for Q1 2026.

  • Quarterly results put Net Cash Flow at $44.3 million for Q1 2026, up 35633.87% from a year ago — trailing twelve months through Mar 2026 was $174.4 million (up 306.8% YoY), and the annual figure for FY2025 was $130.2 million, up 187.03%.
  • Net Cash Flow reached $44.3 million in Q1 2026 per BHVN's latest filing, roughly flat from $44.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $190.8 million in Q4 2022 and bottomed at -$154.3 million in Q3 2024.
  • Median Net Cash Flow over the past 5 years was $14.4 million (2024), compared with a mean of $11.8 million.
  • The largest annual shift saw Net Cash Flow crashed 376.48% in 2023 before it surged 35633.87% in 2026.
  • Over 5 years, Net Cash Flow stood at $190.8 million in 2022, then plummeted by 33.72% to $126.4 million in 2023, then crashed by 88.58% to $14.4 million in 2024, then surged by 207.55% to $44.4 million in 2025, then fell by 0.19% to $44.3 million in 2026.
  • Business Quant data shows Net Cash Flow for BHVN at $44.3 million in Q1 2026, $44.4 million in Q4 2025, and $19.4 million in Q3 2025.